BT Group plc (FRA:BTQ)
2.160
0.00 (0.00%)
Last updated: Oct 24, 2025, 8:07 AM CET
BT Group Employees
BT Group had 85,300 employees as of March 31, 2025. The number of employees decreased by 6,400 or -6.98% compared to the previous year.
Employees
85,300
Change (1Y)
-6,400
Growth (1Y)
-6.98%
Revenue / Employee
€285,290
Profits / Employee
€14,770
Market Cap
21.00B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 85,300 | -6,400 | -6.98% |
| Mar 31, 2024 | 91,700 | -5,400 | -5.56% |
| Mar 31, 2023 | 97,100 | -1,300 | -1.32% |
| Mar 31, 2022 | 98,400 | -1,300 | -1.30% |
| Mar 31, 2021 | 99,700 | -5,600 | -5.32% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 327,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
| Siemens Healthineers AG | 72,000 |
BT Group News
- 4 days ago - Internet outages at HMRC, Zoom and Snapchat reported after AWS disruption - Evening Standard
- 4 days ago - Transgene and BioInvent's Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors - Accesswire
- 4 days ago - Transgene and BioInvent's Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors - GlobeNewsWire
- 6 days ago - Heathrow puts Jansen on runway as next chairman - Sky News
- 7 days ago - More 'punitive' tax hikes would wreck economy: BT and Whitbread in stark warning ahead of Budget - This is Money
- 7 days ago - Man Arrested For Threatening Karnataka Minister Priyank Kharge Over RSS Ban - NDTV
- 7 days ago - Proposed changes to business rates ‘risk slowdown’ in investment, warns BT - Evening Standard
- 11 days ago - Transgene and BioInvent to Present Translational Data and Updated Clinical Results on Armed Oncolytic Virus BT-001, at ESMO 2025 - Accesswire